Donald C. Manning

PCRX

CHIEF MEDICAL OFFICER · PACIRA BIOSCIENCES, INC. · CIK 0001775268

FILING MIX · LIFETIME67%/33%

BUYS

SELLS

TOTAL VALUE

$306.8K

COMPANIES

ACTIVE SINCE

Jun 2020

HOLDINGS NOW

29,520

AVG SELL PX

$61.61

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

2 backtested trades · 8 horizonsHow are these numbers computed? →

Forward-return performance of every backtestable P/S trade by Donald C. Manning, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	2	+100.00%	-1.72%	+0.42%	-2.14%	-2.14%	—
14d	2	+50.00%	-0.53%	+0.47%	-1.00%	-1.00%	—
30d	2	+100.00%	-5.82%	+2.95%	-8.78%	-8.78%	—
60d	2	+50.00%	-2.10%	+4.79%	-6.88%	-6.88%	—
90d	2	+100.00%	-5.75%	+7.52%	-13.27%	-13.27%	—
180d	2	+100.00%	-14.26%	+10.30%	-24.56%	-24.56%	—
1y	2	+50.00%	+1.52%	-0.36%	+1.88%	+1.88%	—
2y	2	+100.00%	-38.02%	+4.80%	-42.82%	-42.82%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

PCRX · 29,520 shares · as of Jun 9, 2021

Trading cadence · quarterly flow

BUY ● SELL ●

2020

2021

FLOW · 4 buys / 2 sellsCOVERAGE · 5 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
PCRX PACIRA BIOSCIENCES, INC.	PURCHASEGRANT Stock grant	15,000	—	—	15,000	Jun 9, 2021	Jun 11, 2021 ↗	View →
PCRX PACIRA BIOSCIENCES, INC.	PURCHASEGRANT Stock grant	6,000	—	—	29,520	Jun 9, 2021	Jun 11, 2021 ↗	View →
PCRX PACIRA BIOSCIENCES, INC.	SALE Chief Medical Officer	2,600	$61.14	$159.0K	23,520	Jun 8, 2021	Jun 10, 2021 ↗	View →
PCRX PACIRA BIOSCIENCES, INC.	SALE Chief Medical Officer	2,380	$62.12	$147.9K	26,120	Jun 2, 2021	Jun 4, 2021 ↗	View →
PCRX PACIRA BIOSCIENCES, INC.	PURCHASEGRANT Stock grant	71,300	—	—	71,300	Jun 2, 2020	Jun 4, 2020 ↗	View →
PCRX PACIRA BIOSCIENCES, INC.	PURCHASEGRANT Stock grant	28,500	—	—	28,500	Jun 2, 2020	Jun 4, 2020 ↗	View →

Other insiders · PCRX

Loading peer insiders…

About this filer

CIK 0001775268

ROLE

Chief Medical Officer

PRIMARY

PCRX

COMPANIES

ACTIVE SINCE

Jun 2020

MARKETPEEL · /INSIDER/0001775268DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Donald C. Manning

The morning brief, before the bell.